Therapeutics Subscribe to Therapeutics
Competitor Landscape: Spondyloarthritis
Competitor Landscape: Spondyloarthritis
Summary
Sociable Pharma’s Treatment Landscape’ contains evaluations of ongoing development activities within the spondyloarthritis (SpA) market, analysis of current & potential future...
Multiple Sclerosis: Dynamic Market Forecast to 2026
Multiple Sclerosis: Dynamic Market Forecast to 2026
Summary
Multiple Sclerosis (MS) is a rapidly evolving field in which new developments are constantly influencing the market landscape.
The Dynamic Market Forecast is designed to help clients...
Competitor Landscape: Non-alcoholic Steatohepatitis (NASH)
Competitor Landscape: Non-alcoholic Steatohepatitis (NASH)
Summary
Sociable Pharma’s Treatment Landscape’ contains evaluations of ongoing development activities within the NASH market, analysis of current & potential future...
Competitor Landscape: Graft Versus Host Disease (GVHD)
Competitor Landscape: Graft Versus Host Disease (GVHD)
Summary
Sociable Pharma’s Treatment Landscape’ contains evaluations of ongoing development activities within the graft versus host disease (GVHD) market, analysis of current...
Competitor Landscape: Systemic Sclerosis (Scleroderma)
Competitor Landscape: Systemic Sclerosis (Scleroderma)
Summary
Sociable Pharma’s Treatment Landscape’ contains evaluations of ongoing development activities within the Systemic Sclerosis (Scleroderma) market, analysis of current...
Atopic Dermatitis: Epidemiology Forecast to 2027
Atopic Dermatitis: Epidemiology Forecast to 2027
Summary
Atopic dermatitis (AD) or atopic eczema is a chronic inflammatory skin disease characterized by itchy skin lesions and rashes. Although the condition affects people of all ages, it is...
Malaria: Epidemiology Forecast to 2027
Malaria: Epidemiology Forecast to 2027
Summary
Malaria is a vector-borne disease caused by parasites of the genus Plasmodium. Malaria is transmitted through the bite of the female Anopheles mosquito. Upon infecting a new human host, parasites...
Pompe Disease: Epidemiology Forecast to 2027
Pompe Disease: Epidemiology Forecast to 2027
Summary
Pompe disease is a rare multisystem disorder caused by pathogenic variations in the GAA gene, which contains the information for production and function of a protein called acid alpha-glucosidase...
Pompe Disease: Opportunity Analysis and Forecasts to 2027
Pompe Disease: Opportunity Analysis and Forecasts to 2027
Summary
Pompe disease (PD) is a rare genetic disorder resulting in the accumulation of glycogen with lysosomes in various tissues of the body. It is caused by a multitude of different...
Atopic Dermatitis: Global Drug Forecast and Market Analysis to 2027
Atopic Dermatitis: Global Drug Forecast and Market Analysis to 2027
Summary
Atopic Dermatitis is a widespread chronic inflammatory skin condition that can affect patients of all ages and is the result of a complex interplay of environmental,...